XBRA
COM:XBRANE
Xbrane Biopharma
- Stock
Last Close
0.20
21/11 16:29
Market Cap
339.03M
Beta: -
Volume Today
8.50M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -2.11M - | -2.57M 22.15% | -11.55M 348.73% | -33.22M 187.61% | -44.94M 35.26% | -13.12M 70.81% | -166.04M 1,166.01% | -226.03M 36.13% | -188.38M 16.66% | -172.51M 8.42% | -322.03M 86.67% | |
depreciation and amortization | 54.66K - | 1.44M 2,536.92% | 8.54M 492.46% | 4.32M - | 7.33M 69.47% | 6.57M 10.37% | 13.00M 97.96% | 16.58M 27.53% | 33.74M 103.52% | |||
deferred income tax | 12.35M - | -9.06M - | -25.42M 180.46% | |||||||||
stock based compensation | 978K - | 2.09M 113.91% | 1.29M 38.19% | 4.55M 251.97% | 8.85M 94.35% | |||||||
change in working capital | -90.19K - | -151.03K 67.46% | -1.98M 1,210.04% | -14.68M 641.80% | 4.28M 129.18% | 54.87M 1,181.09% | -7.27M 113.25% | -18.63M 156.23% | -38.41M 106.22% | -30.73M 20% | -119.16M 287.73% | |
accounts receivables | -28.29M - | -51.33M 81.45% | -61.09M 19.02% | 1.70M 102.78% | -85.13M 5,110.71% | |||||||
inventory | -160.91K - | -2.34M 1,351.69% | -568K 75.68% | -2.28M 301.41% | -50.26M - | -56.60M 12.61% | ||||||
accounts payables | 42.97M - | 32.70M 23.90% | 22.67M 30.66% | 17.83M 21.36% | 22.57M 26.60% | |||||||
other working capital | -1.82M - | -12.34M 578.95% | 4.85M 139.31% | 57.15M 1,078.09% | -21.95M 138.41% | |||||||
other non cash items | 94 - | 2.13K 2,165.96% | -298.66K 14,121.60% | -66.90K 77.60% | 3.80M 5,784.35% | -348K 109.15% | 2.95M 947.41% | -1.61M 154.66% | -1.30M 19.11% | 9.33M 815.26% | 770K 91.74% | |
net cash provided by operating activities | -2.20M - | -2.67M 21.43% | -12.39M 364.20% | -39.43M 218.30% | -36.85M 6.54% | 46.71M 226.75% | -148.59M 418.13% | -238.41M 60.45% | -219.61M 7.88% | -193.92M 11.70% | -406.68M 109.72% | |
investments in property plant and equipment | -187.22K - | -1.15M 512.28% | -12.09M 954.42% | -3.35M 72.31% | -1.60M 52.26% | -1.19M 25.72% | -3.85M 224.77% | -77.35M 1,906.49% | -60.13M 22.27% | -16.77M 72.11% | ||
acquisitions net | 19.47K - | |||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | -634.70K - | |||||||||||
net cash used for investing activites | -187.22K - | -1.13M 501.88% | -12.72M 1,028.97% | -3.35M 73.69% | -1.60M 52.26% | -1.19M 25.72% | -3.85M 224.77% | -77.35M 1,906.49% | -60.13M 22.27% | -16.77M 72.11% | ||
debt repayment | -131K - | -140K 6.87% | -12K 91.43% | -7.27M 60,508.33% | -8.34M 14.63% | -193.55M 2,221.58% | ||||||
common stock issued | 10.71M - | 180.01K 98.32% | 90.58M - | 20.00M 77.91% | 3.25M 83.75% | 252.46M 7,667.91% | 346.45M 37.23% | 380.87M 9.94% | 170.55M 55.22% | 119.06M 30.19% | ||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 10M - | -9.78M 197.78% | -3.28M 66.50% | 44.61M 1,461.75% | -36.28M 181.32% | -23.71M 34.64% | -24.23M 2.20% | -13.35M 44.91% | -13.91M 4.19% | |||
net cash used provided by financing activities | 10.71M - | 180.01K 98.32% | 10M 5,455.37% | 80.80M 707.99% | 16.73M 79.30% | 47.73M 185.33% | 216.04M 352.63% | 322.72M 49.38% | 349.37M 8.26% | 148.86M 57.39% | 298.70M 100.65% | |
effect of forex changes on cash | -1 - | 2 300% | 33K 1,649,900% | 230K 596.97% | -3.04M 1,421.30% | -1.52M 49.98% | 1.39M 191.64% | 4.05M 190.45% | -3.84M 194.93% | |||
net change in cash | 8.51M - | -2.68M 131.43% | -3.51M 31.32% | 28.65M 915.44% | -23.43M 181.80% | 93.07M 497.14% | 63.23M 32.07% | 78.94M 24.86% | 52.04M 34.08% | -101.19M 294.44% | -128.59M 27.08% | |
cash at beginning of period | 365.09K - | 8.88M 2,331.36% | 6.20M 30.14% | 2.69M 56.66% | 31.34M 1,066.04% | 7.90M 74.78% | 100.97M 1,177.64% | 164.20M 62.62% | 243.14M 48.08% | 295.18M 21.40% | 193.99M 34.28% | |
cash at end of period | 8.88M - | 6.20M 30.14% | 2.69M 56.66% | 31.34M 1,066.05% | 7.90M 74.78% | 100.97M 1,177.64% | 164.20M 62.62% | 243.14M 48.08% | 295.18M 21.40% | 193.99M 34.28% | 65.40M 66.29% | |
operating cash flow | -2.20M - | -2.67M 21.43% | -12.39M 364.20% | -39.43M 218.30% | -36.85M 6.54% | 46.71M 226.75% | -148.59M 418.13% | -238.41M 60.45% | -219.61M 7.88% | -193.92M 11.70% | -406.68M 109.72% | |
capital expenditure | -187.22K - | -1.15M 512.28% | -12.09M 954.42% | -3.35M 72.31% | -1.60M 52.26% | -1.19M 25.72% | -3.85M 224.77% | -77.35M 1,906.49% | -60.13M 22.27% | -16.77M 72.11% | ||
free cash flow | -2.20M - | -2.86M 29.95% | -13.53M 373.91% | -51.51M 280.65% | -40.20M 21.97% | 45.11M 212.22% | -149.78M 432.03% | -242.26M 61.75% | -296.96M 22.58% | -254.04M 14.45% | -423.45M 66.68% |
All numbers in (except ratios and percentages)